Welcome Guest
Sign In
Register
Home
Analytical Testing
Clinical Trials
Contract Research
Logistics
Manufacturing
Articles
Facility Tours
News
Events
Videos
Clinical Trials Documentary
A Solid Dosage Future Documentary
Whitepapers/App Notes
Issue Archives
Company Focus
Service Directory
Register
Sign In
INC Research Corporate Profile
Summary
Resources
Related Product Categories
Cardiovascular CRO (Contract / Clinical Research Organization)
Clinical Trial Biostatistics Outsourcing (Biostatistical Services)
Clinical Trial Data Management Outsourcing / Data Management CRO
Clinical Trial Patient Recruitment Services
Clinical Trial Project Management CRO
Clinical Trial Protocol Development Services (CRO)
Contract Clinical Medical Writing Services (Clinical Writing)
Contract Clinical Trial Monitoring Services
Contract Clinical Trial Site Management Services (CRO)
Contract Clinical Trials Regulatory Affairs Consulting Services
Diabetes CRO (Contract / Clinical Research Organization)
Medical Device CRO (Contract / Clinical Research Organization)
Neurology CRO (Contract Clinical Research Organization)
Oncology CRO / Cancer CRO (Contract / Clinical Research Organization)
Ophthalmology CRO (Contract / Clinical Research Organization)
Pharmaceutical Clinical Study Design Services (CRO)
Phase I Clinical Research Organizations (Phase I CRO)
Phase II Clinical Research Organizations (Phase II CRO)
Phase III Clinical Research Organizations (Phase III CRO)
Phase IV Clinical Research Organizations (Phase IV CRO)
Respiratory CRO (Contract / Clinical Research Organization)
Content
An Interview With...Maggie Adamski, Director, Clinical Trial Recruitment, Communications, INC Research/...
There’s a disconnect in the protocol design and the patient treatment pathway, behaviors and diversity that remains the most critical issue facing the industry.